Abstract
The analysis of cDNA clones for human (1,2) and rat (3) insulin-like growth factor-II (IGF-II)1 has led to the prediction that the processed forms of the growth factors, i.e. Mr = 7422 (67 amino acids) for human IGF-II are synthesized as precursors with an extension of 89 amino acids at the carboxyl terminus. This extension is termed the E domain. Moses et al (4) identified two precursor forms of rat IGF-II (originally designated multiplication-stimulating activity) in the conditioned medium of Buffalo rat liver, i.e. BRL-3A, cells with appMrs = 16,270 (MSA-1) and 8,700 (MSA-II). Human serum, spinal fluid and tissue extracts also contain high Mr forms of IGF-II (5-8). Zumstein et al., (5) have purified a Mr = 10,000 variant form of IGF-II from serum that contained Cys-Gly-Asp for Ser33 in the C domain and an E domain extension of 21- amino acids. This 10 kDa IGF-II may be similar or identical to the “big IGF-II” that was reported to be present in human serum and in spinal fluid (6). We have isolated a still larger form of IGF-II from normal human serum (7). N-terminal amino acid sequence analysis through the first 28 residues and RRAs using rat placental membranes established it as a form of IGF-II. As evidenced from its mobility during SDS-PAGE, it has an appMr = 15,000. Very recently, Hudgins et al., (8) established that normal human serum contains several forms of precursor IGF- II with acidic isoelectric points, i.e. pI’s. The mass and acidic nature of one of these molecules with an apparent Mr= 15,000 was contributed, in part, by polysaccharides and sialic acids, respectively (8). These results may explain the observations of several investigators that extracts from the tissues and serum of patients with malignant tumors contain a broad size range of IGF-II (2,9,10).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
G.I. Bell, J.P. Merryweather, R. Sanchez-Pescador, M.M. Stempien, L.P. Priestley, J. Scott, L.B. Rall, Sequence of a cDNA clone encoding human preproinsulin-like growth factor II, Nature (London) 310:775 (1984).
W.H. Daughaday, and P. Rotwein, Insulin-like Growth Factors I and II Peptide, Messenger Ribonucleic Acid and Gene Structures, Serum, and Tissue Concentrations Endocrine Rev. 10:68 (1989).
H.J. Whitfield, C.B. Bruni, R. Frunzio, J.E. Terrell, S.P. Nissley, M.M. Rechler, Isolation of a cDNA clone encoding the rat insulin-like growth factor-II precursor, Nature (London) 312:277 (1984).
A.C. Moses, S.P. Nissley, P.A. Short, M.M. Rechler, J. M. Podskalny, Purification and characterization of multiplication-stimulating activity, Eur. J. Biochem. 103:387 (1980).
P.P. Zumstein, C. Luthi, R. Humbel, Amino acid sequence of a variant pro-form of insulin-like growth factor II, Proc. Natl. Acad. Sci. (USA) 82: 169 (1985).
G. Haselbacher, R. Humbel, Evidence for two species of insulin-like growth factor II (IGF-II and “big” IGF-II) in human spinal fluid, Endocrinology110:1822(1982).
L.K. Gowan, B. Hampton, D.J. Hill, R.J. Schlueter, and J.F. Perdue, Purification and characterization of a unique high Mr form of insulin-like growth factor II, Endocrinology 121:449 (1986).
W.R. Hudgins, B. Hampton, W.H. Burgess, and J.F. Perdue, 2nd International IGF Symposium, San Francisco, CA, January 1991. Abstract, in press
G.K. Haselbacher, J. C. Irmilnger, J. Zapf, W.H. Ziegler, and R.E. Humbel, Insulin-like growth factor II in human adrenal pheochromocytomas and Wilms’ tumors: Expression at the mRNA and protein level, Proc. Natl. Acad. Sci., (USA) 84:1104 (1987).
W.H. Daughaday, M. Kapadia, Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors, Proc. Nat. Acad. Sci. 86:6778 (1989).
H. Tanaka, O. Asami, T. Hayano, I. Sasaki, Y. Yoshitake, and K. Nishikawa, Identification of a family of insulin-like growth factor II secreted by cultured rat epithelial-like cell line 18, 54-SF: Application of amonoclonal antibody, Endocrinology124:870 (1989).
B. Hampton, W.H. Burgess, D.R. Marshak, K.J. Cullen, and J.F. Perdue, Purification and characterization of an insulin-like growth factor II variant from human plasma, J. Biol. Chem. 264:19155 (1989).
U.K. Laemmli, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature (London) 227:680 (1970).
W.M. Hunter, and F.C. Greenwood, Preparation of iodine-131-labeled human growth hormone of high specific activity, Nature 194:495 (1962).
J.F. Perdue, J.K. Chan, C. Thibault, P. Radaj, B. Mills, W.H. Daughaday, The biochemical characterization of detergent-solubilized insulin-like growth factor II receptors from rat placenta, J. Biol. Chem. 258:7800 (1983).
R.W. Furlanetto, L.E. Underwood, J.J. Van Wyk, A.J. D’Ercole, Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay, J. Clin. Invest. 60:648 (1977).
C. D. Scott, J.L. Martin, R.C. Baxter, Production of insulin-like growth factor I and its binding protein by adult rat hepatocytes in primary culture, Endocrinology 116:1094 (1985).
M.L. Davenport, M.E. Svobolda, K.L. Koerber, J.J. VanWyk, D.R. Clemmons, and L.E. Underwood, Serum concentrations of insulin-like growth factor II are not changed by short term fasting and re-feeding, J. Clin. Endo. Metab. 67:1231 (1988).
J.L. Martin, and R.C. Baxter, Insulin-like growth factor binding protein from human plasma: Purification and characterization, J. Biol. Chem. 261:8754 (1986).
W.R. Hudgins, and J.F. Perdue, High Molecular Weight Forms of Insulin-Like Growth Factor-II, 72nd Annual Meeting of the Endocrine Society, Atlanta, Georgia, June 1990, Abs. P. 306.
W.H. Daughaday, J.-G. Wu, S.-D. Lee, and M. Kapadia, Abnormal Processing of pro-IGF-II in Patients with Hepatoma and in Some Hepatitis B Virus Antibody-Positive Asymptomatic Individuals, J. Lab. Clin. Med. 115:555 (1990).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Plenum Press, New York
About this chapter
Cite this chapter
Perdue, J.F., Gowan, L.K., Hudgins, W.R., Scheuermann, J., Foster, B., Brown, S.N. (1991). Development of a Specific Radioimmuno Assay for E Domain Containing Forms of Insulin-Like Growth Factor II. In: Raizada, M.K., LeRoith, D. (eds) Molecular Biology and Physiology of Insulin and Insulin-Like Growth Factors. Advances in Experimental Medicine and Biology, vol 293. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5949-4_5
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5949-4_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5951-7
Online ISBN: 978-1-4684-5949-4
eBook Packages: Springer Book Archive